Literature DB >> 12938201

Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections.

Kazunori Oishi1, Shingo Inoue, Maria T D D Cinco, Efren M Dimaano, Maria T P Alera, Jhoe A R Alfon, Ferdinand Abanes, Deu J M Cruz, Ronald R Matias, Hiromi Matsuura, Futoshi Hasebe, Susumu Tanimura, Atsushi Kumatori, Kouichi Morita, Filipinas F Natividad, Tsuyoshi Nagatake.   

Abstract

Although the public health impact of dengue is increasing rapidly, the mechanism of thrombocytopenia in this disease remains unknown. To elucidate this mechanism, the relationship between platelet-associated IgG (PAIgG) and platelet count in 53 patients in the acute phase of secondary dengue virus infection was investigated in a prospective-hospital-based study. A significant inverse correlation between the two parameters was found in these patients, while no correlation was observed in healthy volunteers. The low baseline platelet counts during the acute phase in 12 patients with secondary dengue virus infection significantly increased during the convalescent phase, while the increased PAIgG levels during the acute phase in these patients significantly decreased during the convalescent phase. Anti-platelet IgG autoantibody was detected rarely in the plasma of 53 patients with secondary dengue infection. The involvement of anti-dengue virus IgG was also shown in platelets from all of 8 patients in the acute phase of secondary dengue virus infection. These findings suggest that PAIgG formation involving anti-dengue virus IgG plays a pivotal role in the induction of transient thrombocytopenia during the acute phase of secondary dengue virus infection. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938201     DOI: 10.1002/jmv.10478

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

Review 1.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Intravenous immunoglobulin for severe thrombocytopenia in secondary dengue.

Authors:  Vinod Kumar; Kartik Gupta; Manish Soneja; Ashutosh Biswas
Journal:  BMJ Case Rep       Date:  2018-06-27

3.  Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.

Authors:  M Saito; K Oishi; S Inoue; E M Dimaano; M T P Alera; A M P Robles; B D Estrella; A Kumatori; K Moji; M T Alonzo; C C Buerano; R R Matias; K Morita; F F Natividad; T Nagatake
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

4.  Role of CD61+ cells in thrombocytopenia of dengue patients.

Authors:  Sansanee Noisakran; Nattawat Onlamoon; Kovit Pattanapanyasat; Hui-Mien Hsiao; Pucharee Songprakhon; Nasikarn Angkasekwinai; Kulkanya Chokephaibulkit; Francois Villinger; Aftab A Ansari; Guey Chuen Perng
Journal:  Int J Hematol       Date:  2012-09-18       Impact factor: 2.490

Review 5.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  The importance of hematopoietic progenitor cells in dengue.

Authors:  Jih-Jin Tsai; Li-Teh Liu; Ko Chang; Shu-Hui Wang; Hui-Mien Hsiao; Kristina B Clark; Guey Chuen Perng
Journal:  Ther Adv Hematol       Date:  2012-02

Review 7.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

Review 8.  Current progress in dengue vaccines.

Authors:  Shu-Wen Wan; Chiou-Feng Lin; Shuying Wang; Yu-Hung Chen; Trai-Ming Yeh; Hsiao-Sheng Liu; Robert Anderson; Yee-Shin Lin
Journal:  J Biomed Sci       Date:  2013-06-13       Impact factor: 8.410

Review 9.  Can non-human primates serve as models for investigating dengue disease pathogenesis?

Authors:  Kristina B Clark; Nattawat Onlamoon; Hui-Mien Hsiao; Guey C Perng; Francois Villinger
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

10.  Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen.

Authors:  Antônio J S Gonçalves; Edson R A Oliveira; Simone M Costa; Marciano V Paes; Juliana F A Silva; Adriana S Azevedo; Marcio Mantuano-Barradas; Ana Cristina M A Nogueira; Cecília J Almeida; Ada M B Alves
Journal:  PLoS Negl Trop Dis       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.